GR2102

· Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR2102, covering 2024-08-22 to 2024-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult [Phase 1]